Cover Image

Acquired amegakaryocytic thrombocytopenic purpura progressing into aplastic anemia

In this article, we report a case of newly acquired AATP without an associated autoimmune disease, refractory to corticoids, intravenous immunoglobulin (IVIG) and second-generation TPO (thrombopoietin) agonists, which have recently been approved for the treatment of thrombocytopenia. Finally, in acc...

Full description

Saved in:
Bibliographic Details
Main Authors: Novotný, Jan Philipp (Author) , Köhler, Birgit (Author) , Max, Regina (Author) , Egerer, Gerlinde (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Prague medical report
Year: 2017, Volume: 118, Issue: 4, Pages: 147-155
ISSN:2336-2936
DOI:10.14712/23362936.2017.16
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.14712/23362936.2017.16
Verlag, kostenfrei, Volltext: https://pmr.lf1.cuni.cz/118/4/0147/
Get full text
Author Notes:Jan Philipp Novotný, Birgit Köhler, Regina Max, Gerlinde Egerer
Description
Summary:In this article, we report a case of newly acquired AATP without an associated autoimmune disease, refractory to corticoids, intravenous immunoglobulin (IVIG) and second-generation TPO (thrombopoietin) agonists, which have recently been approved for the treatment of thrombocytopenia. Finally, in accordance with other reports, disease progression into aplastic anemia has occurred.
Item Description:Gesehen am 20.08.2018
Physical Description:Online Resource
ISSN:2336-2936
DOI:10.14712/23362936.2017.16

Similar Items